By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
| Currency | US Dollars |
| Share Price | $ 121.22 |
| Change Today | $ -1.40 |
| % Change | -1.14 % |
| 52 Week High | $128.07 |
| 52 Week Low | $89.14 |
| Volume | 10,417,014 |
| Shares Issued | 1,246.00m |
| Market Cap | $151,040m |
| RiskGrade | 120 |
| Strong Buy | 9 |
| Buy | 13 |
| Neutral | 6 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 29 |

| Time | Volume / Share Price |
| 16:00 | 1,885,589 @ $121.22 |
| 15:59 | 6,449 @ $121.26 |
| 15:59 | 100 @ $121.26 |
| 15:59 | 2,700 @ $121.25 |
| 15:59 | 825 @ $121.25 |
You are here: research